ITCC-061 EZH-102
A Phase 1 Study of EPZ-6438 (an EZH2 Inhibitor) in Pediatric Patients with Relapsed/Refractory INI1-Negative Tumors or Synovial Sarcomas
Promotor Name : EPIZYME
Investigator Name : F. BOURDEAUT
Trial registered on clinicaltrial.gov: NCT02601937